{"code":"MED","name":"Media/Publishing","totalSpending":176687127.26,"totalFilings":8437,"yearlySpending":[{"year":2018,"income":19399052,"filings":995},{"year":2019,"income":20093968.42,"filings":1065},{"year":2020,"income":26263050,"filings":1359},{"year":2021,"income":27414500,"filings":1295},{"year":2022,"income":29389606.84,"filings":1364},{"year":2024,"income":24234200,"filings":1123},{"year":2025,"income":29892750,"filings":1236}],"topClients":[{"name":"COALITION OF EPSCOR STATES","income":3050000},{"name":"AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA)","income":2510000},{"name":"MASS GENERAL BRIGHAM","income":2420000},{"name":"AIR LIQUIDE USA LLC","income":2338000},{"name":"OMEROS CORPORATION","income":2155000},{"name":"ALLIANCE FOR BIOSECURITY","income":2010000},{"name":"PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION","income":1980000},{"name":"TRAVERE THERAPEUTICS","income":1882500},{"name":"AMGEN USA, INC.","income":1600000},{"name":"UAB HEALTH SYSTEM","income":1550000},{"name":"LOMA LINDA UNIVERSITY MEDICAL CENTER","income":1541443},{"name":"CONTINUING MEDICAL EDUCATION COALITION","income":1540000},{"name":"SANOFI, U.S.","income":1490000},{"name":"IQVIA","income":1490000},{"name":"CHILDREN'S NATIONAL MEDICAL CENTER","income":1400000},{"name":"SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION","income":1400000},{"name":"ASTCT","income":1390000},{"name":"ASSOCIATION FOR MOLECULAR PATHOLOGY","income":1361000},{"name":"JAZZ PHARMACEUTICALS","income":1310000},{"name":"AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION","income":1250000},{"name":"QORVO","income":1170000},{"name":"MEDISYS HEALTH NETWORK","income":1161913.8399999999},{"name":"MISSISSIPPI STATE UNIVERSITY","income":1150000},{"name":"UNIVERSITY OF ALABAMA SYSTEM","income":1140000},{"name":"INVITAE INC.","income":1115500},{"name":"MYRIAD GENETICS, INC.","income":1060000},{"name":"CITY OF HOPE MEDICAL CENTER","income":1050000},{"name":"AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE","income":1030000},{"name":"EXELA PHARMA SCIENCES, LLC","income":1002000},{"name":"MEDICAL UNIVERSITY HOSPITAL AUTHORITY","income":960000},{"name":"LABORATORY CORPORATIONS OF AMERICA HOLDINGS","income":940000},{"name":"CSL BEHRING","income":930000},{"name":"TENET BUSINESS SERVICES CORPORATION","income":930000},{"name":"LIFESCIENCE LOGISTICS","income":930000},{"name":"CARIS SCIENCE INC","income":920000},{"name":"NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION)","income":910000},{"name":"UNITED FOR MEDICAL RESEARCH","income":900000},{"name":"ABBVIE, INC.","income":900000},{"name":"ADVANCED MEDICAL TECHNOLOGY ASSOCIATION","income":850000},{"name":"PANCREATIC CANCER ACTION NETWORK (PANCAN)","income":840000},{"name":"IMPACT JOURNALS, LLC","income":840000},{"name":"APIJECT SYSTEMS CORP.","income":840000},{"name":"COALITION FOR 21ST CENTURY MEDICINE","income":811000},{"name":"BLUE EARTH DIAGNOSTICS, INC.","income":800000},{"name":"COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION","income":800000},{"name":"REVELLE AESTHETICS, INC.","income":800000},{"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)","income":780000},{"name":"VERTEX PHARMACEUTICALS INCORPORATED","income":780000},{"name":"WALGREEN CO.","income":780000},{"name":"AMERICAN SOCIETY FOR RADIATION ONCOLOGY","income":770000}],"topFirms":[{"name":"CORNERSTONE GOVERNMENT AFFAIRS, INC.","income":10720000},{"name":"VAN SCOYOC ASSOCIATES","income":9580000},{"name":"FORBES-TATE","income":6100000},{"name":"BROWNSTEIN HYATT FARBER SCHRECK, LLP","income":6060000},{"name":"THE PETRIZZO GROUP, INC.","income":5815000},{"name":"WILLIAMS AND JENSEN, PLLC","income":5360000},{"name":"BALLARD PARTNERS","income":4890000},{"name":"SQUIRE PATTON BOGGS","income":4710000},{"name":"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.","income":4210000},{"name":"THORN RUN PARTNERS","income":3350000},{"name":"O'NEILL, ATHY & CASEY, P.C.","income":3080000},{"name":"CAPITOL COUNSEL LLC","income":2980000},{"name":"BRACEWELL LLP","income":2868000},{"name":"ALSTON & BIRD LLP","income":2860000},{"name":"IPOLICY SOLUTIONS","income":2766750},{"name":"MANATT, PHELPS, AND PHILLIPS","income":2763356.84},{"name":"COVINGTON & BURLING LLP","income":2540000},{"name":"THE CONAFAY GROUP, LLC","income":2170000},{"name":"POWERS PYLES SUTTER & VERVILLE, P.C.","income":2135000},{"name":"HOLLAND & KNIGHT LLP","income":2130000},{"name":"IMPACT HEALTH POLICY PARTNERS","income":2000000},{"name":"BUCHANAN INGERSOLL & ROONEY PC","income":1750000},{"name":"TIBER CREEK GROUP","income":1590000},{"name":"FOLEY & LARDNER LLP","income":1546000},{"name":"TODD STRATEGY GROUP","income":1530000},{"name":"REPUBLIC CONSULTING, LLC","income":1490000},{"name":"RAMPY NORTHRUP LLC","income":1430000},{"name":"DLA PIPER LLP (US)","income":1390000},{"name":"SMITHBUCKLIN CORPORATION","income":1390000},{"name":"FAEGRE DRINKER BIDDLE & REATH LLP","income":1260000}],"sampleDescriptions":["Raising Canndescent's profile in Washington, DC with federal decision makers; intellectual property issues before the US Patent and Trademark Office; promoting Canndescent's research and development o","Development of government-private partnerships to advance Alzheimer's therapies.","Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition.","Issues related to hospital and other provider-related reimbursement, including: graduate medical education, value-based purchasing programs, post acute care, and inclusion of unique device identifiers","Medicare payment for hyperbaric oxygen therapy;\nUse of hyperbaric oxygen therapy for treatment of PTSD and CTE;\nResearch on effectiveness of HBOT for PTSD and CTE for active duty and retired and disab","Issues related to payment and delivery reforms, Medicaid benefits and childrens hospital reimbursement. Issues related to pediatric research and childrens hospital graduate medical education.","Issues related to FDA diagnostics approval process","Veterans administration (structure, benefits, services, and quality of care)   Family code (UCCJEA) Federal enforcement of parental rights. Veteran suicide epidemic (root causes, actions, programs, ac","FY19 DoD Appropriations;\nFY19 Labor, HHS, Education Appropriations;\nFY19 NDAA;\nIssues related to autism research","Federal government relations service, strategy development and implementation relating to companys status of FDA action on NDA for oral testosterone.","state, foreign ops appropriations; HIV/AIDS-related issues","Educate policymakers and congressional committees on MedStar Health and importance ensuring critical medical transportation and trauma services in the National Capital Region. Work with federal agenci","Issues related to cervical cancer screening.","Drug FDA Approval: CAM2038","Federal government relations service, strategy development and implementation relating to status of FDAs action with regards to the companys NDA.","Federal government relations service, strategy development and implementation relating to regenerative medicine products.","Issues related to medical devices and lab developed tests.","Medicare/Medicaid drug coverage, opioid addiction policy, S.2456 The CARA 2.0 Act of 2018.","Biodefense, Biomedical Advanced Research and Development Authority funding, vaccine research, development, manufacturing and marketing, infectious diseases, cancer, PAHPA, Labor-HHS Appropriations bil","Appropriations for National Asthma Control Program at CDC, H.R. 2285, School Based Respiratory Health Management Act"]}